The influence of cholinesterase inhibitor therapy for dementia on risk of cardiac pacemaker insertion: a retrospective, population-based, health administrative databases study in Ontario, Canada

BACKGROUND: Cholinesterase inhibitors are used to treat the symptoms of dementia and can theoretically cause bradycardia. Previous studies suggest that patients taking these medications have an increased risk of undergoing pacemaker insertion. Since these drugs have a marginal impact on patient outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Allen R, Redpath, Calum J, van Walraven, Carl
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419497/
https://www.ncbi.nlm.nih.gov/pubmed/25927641
http://dx.doi.org/10.1186/s12883-015-0325-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4419497/
https://www.ncbi.nlm.nih.gov/pubmed/25927641
http://dx.doi.org/10.1186/s12883-015-0325-1

Ejemplares similares